Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Meury William, Director. Insider active across 4 companies, notably Syndax Pharmaceuticals Inc. Aggregated, 12 disclosures have been published. Activity tracked since 2 February 2022. The latest transaction was filed on 16 July 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Meury William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
William Meury is a Board Member at Syndax Pharmaceuticals Inc. He contributes to overseeing the company's activities and making strategic decisions. With expertise in the pharmaceutical sector, he plays an important role in guiding the company's research and development initiatives.